Concerns have been raised by senior doctors surrounding the misuse of weight-loss pens in the UK, with some patients ...

It’s unclear what impact a change in presidential administration will have on the proposal to widen access for those with obesity.

The success of GLP-1R-targeting drugs highlights their viability as a treatment approach. Currently, there are four ...

County health officials are warning residents to avoid consuming voluntarily recalled raw milk due to a detection of H5 bird ...

Amgen's MariTide shows promising weight loss results in Phase II for type 2 diabetes. Find out why AMGN stock remains as a strong buy for long-term investors.

Share on Facebook Share on Twitter Under a new rule the Biden administration proposed on Tuesday, millions of Americans with ...

Shares of Eli Lilly LLY and Novo Nordisk NVO were up on Tuesday, likely due to a proposal by President Biden that Medicare ...

Mounjaro is a treatment for Type 2 diabetes that activates GIP and GLP-1 pathways to help regulate blood sugar. It’s part of ...

Eli Lilly topped the list of the 20 biggest pharmas by market cap with a more than 39% improvement year-to-date in its share ...

The microbial therapeutic products market is forecast to grow from USD 17.11 billion in 2022 to USD 30.55 billion by 2030, ...

Lawmakers pushing to regulate pharmacy benefit managers’ business practices face headwinds in this Congress’ final weeks.

Amgen Inc.’s stock was down 7% Tuesday, after the company said a mid-stage trial of its weight-loss treatment MariTide showed ...